CA9 and neoplasm: Targeting CA IX with inhibitors such as sulfonamides, coumarins, and dithiocarbamates blocks its catalytic activity, disrupting pH regulation, and hindering tumor growth, which makes CA IX a promising target for anticancer therapy [14,15,16].